✦ LIBER ✦

First-dose analgesic effect of the cyclo-oxygenase-2 selective inhibitor lumiracoxib in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled comparison with celecoxib [NCT00267215]

✍ Scribed by Ralf H Wittenberg, Ernest Schell, Gerhard Krehan…

Book ID: 120707444
Publisher: BioMed Central
Year: 2006
Tongue: English
Weight: 251 KB
Volume: 8
Category: Article
ISSN: 1478-6354
DOI: 10.1186/ar1854

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

First-dose analgesic effect of the cyclo

First-dose analgesic effect of the cyclo-oxygenase-2 selective inhibitor lumiracoxib in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled comparison with celecoxib [NCT00267215]

✍ Ralf H Wittenberg, Ernest Schell, Gerhard Krehan… 📂 Article 📅 2006 🏛 BioMed Central 🌐 English ⚖ 251 KB

Efficacy and tolerability of lumiracoxib

Efficacy and tolerability of lumiracoxib in the treatmentof osteoarthritis of the knee: A 13-week, randomized, double-blind comparison with celecoxib and placebo

✍ Eric Sheldon; Andre Beaulieu; Zorba Paster; Dipen Dutta; Sue Yu; Victor S. Sloan 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 997 KB

A 2-year randomized, double-blind, place

A 2-year randomized, double-blind, placebo-controlled, multicenter study of an oral selective iNOS inhibitor in subjects with symptomatic osteoarthritis of the knee

✍ M.-P. Hellio le Graverand-Gastineau; R. Clemmer; P. Redifer; R.M. Brunell; C.W. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Comparison of the effect of rofecoxib (a

Comparison of the effect of rofecoxib (a cyclooxygenase 2 inhibitor), ibuprofen, and placebo on the gastroduodenal mucosa of patients with osteoarthritis: A randomized, double-blind, placebo-controlled trial

✍ Christopher Hawkey; Loren Laine; Thomas Simon; Andre Beaulieu; Jose Maldonado-Co 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 155 KB 👁 2 views

A 2-year randomised, double-blind, place

A 2-year randomised, double-blind, placebo-controlled, multicentre study of oral selective iNOS inhibitor, cindunistat (SD-6010), in patients with symptomatic osteoarthritis of the knee

✍ Hellio le Graverand, M.-P.; Clemmer, R. S.; Redifer, P.; Brunell, R. M.; Hayes, 📂 Article 📅 2012 🏛 BMJ Publishing Group 🌐 English ⚖ 352 KB

Efficacy and safety of the COX-2 specifi

Efficacy and safety of the COX-2 specific inhibitor valdecoxib in the management of osteoarthritis of the hip: a randomized, double-blind, placebo-controlled comparison with naproxen

✍ W. Makarowski; William W. Zhao; Terry Bevirt; David P. Recker 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 95 KB